# Bronchogen — dosage, half-life & reference guide | PepVault

Source: https://pepvault.app/peptides/bronchogen

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Library](https://pepvault.app/peptides) [Longevity](https://pepvault.app/peptides#longevity)

# Bronchogen Dosage, half-life & reference guide

Also known as Ala-Glu-Asp-Leu · AEDL peptide

Reviewed November 2026 Evidence: Emerging [Published by PepVault](https://pepvault.app/guides/how-we-research)

A four-amino-acid peptide from the Russian bioregulator program, which its developers describe as a bioregulator for the airways and lungs. In rats with a COPD-like lung disease, a month of it restored the airway lining and calmed inflammation; in the lab it binds DNA. No human study has been published.

- **How often:** Daily
- **Half-life:** Unknown
- **Evidence:** Emerging
- **Routes:** SubQ, Oral capsules

No human study has tested a dose of Bronchogen: the amounts people run are their own protocol, not a reference.

## How it works.

A tetrapeptide, Ala-Glu-Asp-Leu (AEDL), from Vladimir Khavinson's St. Petersburg bioregulator program, which its developers describe as the bioregulator of the bronchi and lungs. In rats given a lung disease like COPD by two months of nitrogen dioxide, a month of Bronchogen restored the airway lining, raised the local immune antibody secretory IgA and the surfactant protein that keeps air sacs open, and calmed neutrophil inflammation, in studies by a St. Petersburg lung research group. In the lab it binds DNA and raised the temperature at which DNA strands separate, which its developers read as a sign it acts on genes. No human study of Bronchogen is indexed on PubMed.

**Commonly reported:** Little to feel; user reports are few.

<!--promo-->

PepVault for iPhone

## Track bronchogen in PepVault

Log each dose, see how many doses are left in the vial, and keep your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Where Bronchogen works.

- ### Immune system

  **In animals.** Raised the local immune antibody secretory IgA and the surfactant protein that keeps air sacs open, and calmed neutrophil inflammation.

An area lights for what a peptide is used for and what people report, with the evidence beside it. It isn’t a promise that it works there.

## Week by week.

What to expect in the first 8 weeks

- **Onset:** Not established (no human data)
- **Peak effect:** Not established
- **Duration:** Courses of about 10 days (community practice)

1. Day 1–10 Community

   ### No human data to set expectations

   Bronchogen has never been studied in people, so any change you notice is yours to judge. Commonly reported: little to feel; some redness or itch where it goes in. A line each day on breathing and energy gives you something honest to compare.

   Updated Nov 2026
2. Day 10–30 Animal

   ### What the rat studies measured

   In rats with a COPD-like lung disease, a month of Bronchogen restored the airway lining and calmed inflammation in the airways. That is a rat model, and no study has tested it in people with lung disease.

   The science

   Kuzubova 2015: COPD modelled in rats by 60 days of intermittent NO2; a month of Bronchogen removed goblet-cell hyperplasia, squamous metaplasia, lymphocytic infiltration and emphysema, restored ciliated cells and raised secretory IgA. Titova 2017: in the same model, lower neutrophilic inflammation, normalized cytokines and enzymes in lavage fluid, more secretory IgA and surfactant protein B.

   Sources

   - Kuzubova et al. (2015)
   - Titova et al. (2017)

   Updated Nov 2026
3. Any day Animal

   ### What Bronchogen is built on

   A four-amino-acid peptide from the Russian bioregulator program, its peptide for the lungs. Its evidence is two rat studies of a COPD-like disease and lab studies of how it binds DNA; there is no human study.

   The science

   Khavinson 2021 review (Table 5): AEDL, Bronchogen, regulation of lung cells. Kuzubova 2015 and Titova 2017: rat NO2 model of COPD (a St. Petersburg pulmonology group). Monaselidze 2011: raised DNA melting temperature by 3.1 °C, not specific to A-T or G-C pairs. Fedoreyeva 2011: preferential binding to CTG-containing sequences.

   Sources

   - Khavinson et al. (2021)
   - Kuzubova et al. (2015)
   - Titova et al. (2017)
   - Monaselidze et al. (2011)
   - Fedoreyeva et al. (2011)

   Updated Nov 2026
4. With Thymalin Community

   ### With the thymus extract

   Bronchogen is sometimes run beside other bioregulators, one per organ. If one of them is Thymalin: its own Russian study reported fewer respiratory infections in older adults. No study has given the two together.

   The science

   Khavinson and Morozov 2003: in 266 older adults followed 6–8 years, acute respiratory infections were 2.0–2.4 times less common with the thymus and pineal extracts than in a control group. Running bioregulators side by side is community practice; this pair has no study.

   Sources

   - Khavinson et al. (2003)

   Updated Nov 2026

Day 1 is the day you start it.

No human study of Bronchogen has been published. The effects come from rat studies by a St. Petersburg lung research group and from lab studies of DNA by its developers.

Preliminary research

## More on bronchogen

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How the vial count works](https://pepvault.app/peptide-vial-tracker-app)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Half-life](https://pepvault.app/glossary/half-life)
- [Stack](https://pepvault.app/glossary/stack)
- [Bioregulator (Khavinson peptide)](https://pepvault.app/glossary/bioregulator)

## A typical run.

### Run notes

- **Cycle:** Run in short courses rather than continuously, like the other bioregulators: community courses run about 10 days, a few times a year. The rat studies gave it for a month. No study in people has tested a course length. Community practice — opinions vary. Not a clinical recommendation.
- **Timing:** No timing has been studied.
- **Routes:** SubQ injection, Oral capsules
- **Stacks:** Thymalin

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-next-mixing&mt=8)

<!--/promo-->

## Safety.

### Common side effects

- Injection-site redness or itch

#### Interactions

No interaction studies exist, including with inhaled medicines for asthma or COPD.

### Safety notes

No safety study exists: no human study of Bronchogen is indexed, so nothing is known about its side effects beyond user reports, or about long-term use. Discuss with your clinician before use, particularly during pregnancy or breastfeeding, or with asthma, COPD or another lung condition, which need their own treatment.

## Goes with.

- [Thymalin](https://pepvault.app/peptides/thymalin)

## One question at a time.

- [Side effects](https://pepvault.app/peptides/bronchogen/side-effects)
- [How long it takes to work](https://pepvault.app/peptides/bronchogen/how-long-to-work)
- [Legal status](https://pepvault.app/peptides/bronchogen/legal-status)
- [The bioregulator family](https://pepvault.app/bioregulators)

## Questions people ask.

### What is Bronchogen?

A four-amino-acid peptide from the Russian bioregulator program, which its developers describe as a bioregulator for the airways and lungs. In rats with a COPD-like lung disease, a month of it restored the airway lining and calmed inflammation; in the lab it binds DNA. No human study has been published.

### How is Bronchogen dosed in research?

The library carries no reference dose for Bronchogen. No human study has tested a dose of Bronchogen: the amounts people run are their own protocol, not a reference.

### How long does Bronchogen last?

The half-life of Bronchogen is unknown (never measured).

### What do people report on Bronchogen?

Commonly reported on Bronchogen: little to feel; user reports are few.

### Is Bronchogen safe?

The research basis for Bronchogen is emerging: primarily preclinical / limited human data. Common side effects in the library: injection-site redness or itch.

### What does Bronchogen stack with?

Common stacks for Bronchogen: Thymalin.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-next-questions&mt=8)

<!--/promo-->

## Research.

The literature

### Search the latest research

[PubMed](https://pubmed.ncbi.nlm.nih.gov/?term=Bronchogen) [Google Scholar](https://scholar.google.com/scholar?q=Bronchogen)

## Reference.

- **Cadence:** Daily
- **Half-life:** Unknown Unknown (never measured)
- **Research basis:** Emerging Primarily preclinical / limited human data

## More longevity peptides

- [Pancragen No reference dose](https://pepvault.app/peptides/pancragen)
- [Cardiogen No reference dose](https://pepvault.app/peptides/cardiogen)
- [Prostamax No reference dose](https://pepvault.app/peptides/prostamax)
- [Ovagen No reference dose](https://pepvault.app/peptides/ovagen)
- [Klotho 0.01–0.1 mg](https://pepvault.app/peptides/klotho)
- [NMN 250–1000 mg](https://pepvault.app/peptides/nmn)

## Free tools

- [Injection guide (3D)](https://pepvault.app/lab/injection)
- [Peptide Sky (3D)](https://pepvault.app/lab/sky)
- [Peptide tier list](https://pepvault.app/lab/tiers)
- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [Half-life & active level](https://pepvault.app/tools/peptide-half-life-calculator)

<!--promo-->

PepVault for iPhone

## Track bronchogen in PepVault

Log each dose, see how many doses are left in the vial, and keep your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Track bronchogen in PepVault

Log each dose, see how many doses are left in the vial, and keep your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## More on bronchogen

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How the vial count works](https://pepvault.app/peptide-vial-tracker-app)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Half-life](https://pepvault.app/glossary/half-life)
- [Stack](https://pepvault.app/glossary/stack)
- [Bioregulator (Khavinson peptide)](https://pepvault.app/glossary/bioregulator)

<!--promo-->

PepVault for iPhone

## Track bronchogen in PepVault

Log each dose, see how many doses are left in the vial, and keep your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

Reviewed November 2026 [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
